You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for SM 16
SM 16 is a potent TGF-β receptor type 1 (TGF-βRI) inhibitor (IC50 = 64 nM in luciferase assay). Selective for TGF-βRI over other ALK family members. Decreases Smad phosphorylation and inhibits tumor growth in a mouse xenograft model. Attenuates increased TGF-β signaling in retinal vessels of diabetic rats. Also prevents intimal thickening and vascular remodeling in rat carotid balloon injury model. Orally bioavailable.
Compound Libraries for SM 16
Technical Data for SM 16
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for SM 16
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for SM 16
The following data is based on the product molecular weight 430.5. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.32 mL||11.61 mL||23.23 mL|
|5 mM||0.46 mL||2.32 mL||4.65 mL|
|10 mM||0.23 mL||1.16 mL||2.32 mL|
|50 mM||0.05 mL||0.23 mL||0.46 mL|
References for SM 16
References are publications that support the biological activity of the product.
Suzuki et al (2007) A novel small-molecule inhibitor of transforming growth factor β type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res. 67 2351 PMID: 17332368
Fu et al (2008) SM16, an orally active TGF-β type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. Arterioscler.Thromb.Vasc.Biol. 28 665 PMID: 18202322
Dagher et al (2017) The increased transforming growth factor-β signaling induced by diabetes protects retinal vessels. Am.J.Pathol. 187 627 PMID: 28162229
If you know of a relevant reference for SM 16, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: SM 16, SM 16 supplier, SM16, TGF-beta, transforming, growth, factor, beta, inhibitors, inhibits, ALK5, ALK4, orally, bioavailable, Receptors, 6245, Tocris Bioscience
Citations for SM 16
Citations are publications that use Tocris products.
Currently there are no citations for SM 16. Do you know of a great paper that uses SM 16 from Tocris? Please let us know.
Reviews for SM 16
There are currently no reviews for this product. Be the first to review SM 16 and earn rewards!
Have you used SM 16?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Stem Cells Scientific Review
Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.